FDA Status
Not FDA-Approved
Claimed Benefits
- Sleep regulation (mixed evidence)
- Chronic pain reduction (pilot)
- Neuroendocrine modulation
Clinical Evidence
4
Human Trials
Phase II
Highest Phase
A rigorous 1992 double-blind trial concluded DSIP's sleep effects were weak and likely placebo-driven.
Read Full Deep Dive
Mechanism, dosing, vendor pricing, and full research citations